Evidence gap analysis
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Recent news and posts
Four projects awarded under the 2023 subsidy round of the of the Care Evaluation and Appropriate Use program by ZonMw
The Care Evaluation and Appropriate Use Program (Zorgevaluatie en Gepast Gebruik, ZE&GG) aims to implement appropriate care by evaluating and implementing knowledge about what constitutes appropriate care. The results of care evaluations within the Program will change medical practice. The Program is a joint initiative of all parties involved in medical specialist care, with the Dutch Organization for Health Research and Development (ZonMw) and the Dutch Healthcare Institute (ZIN) as strategic partners.
In August 2024, four projects submitted applications within the 2023 round have been awarded the subsidy. The detailed description of projects is provided below in individual technology groups.
- Standard check-ups after a total hip or knee replacement: wasted effort or appropriate care? (HAKA study);
- Reduction of treatment duration with (chemo)immunotherapy for lung cancer (DIDAC study);
- Effectiveness of decision support for CVRM in people with cardiovascular diseases (2-DECIDE study);
- The effect of catheter replacement in patients with catheter-associated urinary tract infection (REPLACE study).
These projects will start in December 2024 at the latest.
See more information in Dutch here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.